An MSD spokesperson confirmed that the company has been granted regulatory approval to launch Keytruda in India for the treatment of unresectable or metastatic melanoma and is complying with all local legal and regulatory requirements.
How much does a round of KEYTRUDA cost?
The list price for each indicated dose of KEYTRUDA when given every 3 weeks is $10,268.72. The list price for each indicated dose of KEYTRUDA when given every 6 weeks is $20,537.44. *† Most people will not pay the list price, although it may have an impact on your out-of-pocket costs.
What is the monthly cost of KEYTRUDA?
The drugs must be infused and they are pricey. Keytruda costs about $12,500 a month, or $150,000 a year.
How much does immunotherapy cost in India?
Immunotherapy drugs cost between Rs 80,000 and Rs 1 lakh for a month's treatment. However, there are some patients in whom the shorter dosage is also enough to "charge" their immune system enough to fight the cancer cells.
How much is an injection of Keytruda?
Quantity Per unit Price
--------------------- --------- ----------
4 milliliters $1,342.44 $5,369.77
8 (2 x 4 milliliters) $1,341.26 $10,730.04
Do most insurance companies cover Keytruda?
According to the Keytruda manufacturers, the average person with original Medicare and no supplemental insurance coverage will pay between $1,000 and $1,950 per Keytruda infusion after meeting their deductible.
How long should you stay on Keytruda?
You usually have it for up to 2 years, but some people might have treatment for longer than 2 years.
Why is Keytruda so expensive?
If Keytruda® is not subsidised, the estimated cost is A$150,000 per patient for each year of treatment. Why so expensive? The pharmaceutical industry points to the costs of research and development, including the expense of the large clinical trials needed to confirm efficacy.
What is the average cost of immunotherapy?
Immunotherapies in particular often cost more than $100,000 per patient. Doctors now use immunotherapies in combination, which means those costs can quickly double or triple.Oct 2, 2018
Is immunotherapy approved in India?
Immunotherapy: Scope in India Currently three drugs are available in India - Pembrolizumab (Keytruda®), Nivolumab (Opdivo®, Opdyta®) and Atezolizumab (Tecentriq®) - that are approved by Drug Controller General of India for stage 4 lung cancer patients.Feb 4, 2019
What is the success rate for immunotherapy?
Immunotherapy drugs work better in some cancers than others and while they can be a miracle for some, they fail to work for all patients. Overall response rates are about 15 to 20%.